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enhancement of immune 
maturation in suckling rats by leptin 
and adiponectin supplementation
Blanca Grases-pintó1,2, Mar Abril-Gil1,2, Margarida Castell1,2, Francisco J. pérez-Cano  1,2 & 
Àngels Franch1,2
Leptin and adiponectin, adipokines present in breast milk, have shown immunomodulatory properties. 
The current study aimed to ascertain whether a nutritional supplementation with leptin or adiponectin 
in neonatal rats was able to influence the maturation of the systemic immune response in early life. To 
achieve this, suckling Wistar rats were supplemented with either leptin (0.7 μg/kg/day) or adiponectin 
(35 μg/kg/day) during the whole suckling period. Plasmatic immunoglobulins were quantified, and 
spleen lymphocyte composition and their ability to proliferate and release cytokines were evaluated 
during (day 14) and at the end (day 21) of the suckling period. Rats fed with either adipokine showed 
higher plasma IgM and IgG1 concentrations and adiponectin supplementation also increased 
IgG2a at both studied days (P < 0.05). With regard to the lymphocyte composition, both adipokine 
supplementations increased T cell proportion and both CD4+ and CD8+ T cell subsets after two weeks 
of supplementation (P < 0.05). Moreover, only leptin administration increased NK and NKT cell 
proportions at the end of the suckling period. Finally, both adipokines influenced the cytokine secretion 
pattern by splenocytes. In conclusion, these results suggest that leptin and adiponectin play a role in 
the maturation of the systemic immune response during the suckling period.
It is well known that the neonatal period is critical because the newborn has to be capable of adapting him/herself 
to the new environment, such as the source of nutrients from the umbilical cord to breast milk1. Moreover, at 
birth, the baby is exposed to a large number of microorganisms and foreign proteins, and the neonatal immune 
system (IS) is not yet well prepared to fight them because its innate and acquired immunity is far from that of an 
adult2. The rapid and appropriate development of the IS can prevent a number of neonatal infections. To compen-
sate for the immunological immaturity of the baby, during the gestation the mother gives protection, transferring 
transplacental antibodies and giving anti-infective resistance factors in the amniotic fluid. In the extrauterine life, 
breastfeeding provides high concentrations of protective and immunomodulatory factors3.
Neonatal nutrition is a critical factor for the development of intestinal and systemic IS4. Evidence has shown 
that breast milk is the ideal food for the newborn during the first months of life, as it is nutritionally adapted 
to the requirements of the baby. In addition to macro- and micronutrients, human milk contains numerous 
bioactive factors that promote the development and functionality of the IS as well as other components that pro-
tect against infection5–7. Thus, breast milk contains antimicrobial components, such as immunoglobulin (Ig) A, 
lactoferrin, lysozyme, oligosaccharides, gangliosides, etc. Moreover, milk has bioactive factors that contribute to 
the development and function of the neonatal IS, such as nucleotides, hormones, growth factors and cytokines, 
among others5,8. It also contains maternal leukocytes in an activated phenotype, such as macrophages, neutrophils 
and lymphocytes9. In general, the components found in milk come from the maternal circulation or are synthe-
sized directly in the mammary glands8. All these components are hypothesized to play a key role in the pathway 
between the naïve IS of the infant and the IS of the child10 and that is why breastfed children tend to be healthier 
than formula-fed children11.
Leptin and adiponectin are adipokines synthesized mainly by white adipose tissue. Moreover, they are abun-
dant in breast milk and are able to cross the infant’s intestinal wall and to reach his bloodstream12,13. It is well 
known that these adipokines are involved in the control of energy balance, but it is well described that they also 
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possess immune activity14–16. The vast majority of the studies on the effect of leptin and adiponectin on the IS 
are performed in vitro17,18, and very few have addressed their ex vivo or in vivo functionality19. In addition, there 
are no studies on the effect of these adipokines on neonatal immune response, and therefore, their impact on the 
maturation of the IS in early life is not known.
We have recently described the potential of both adipokines to modulate immune development in early life at 
the intestinal level, where leptin and adiponectin firstly contact with the host defensive system20. We hypothesize 
that these adipokines could also have a role in the development of the IS in early life at the systemic level. The 
particular aim of the present study is to evaluate whether leptin and adiponectin have a modulatory effect on the 
systemic humoral immune response and on the spleen cell immune functionality, a secondary lymphoid tissue 
representative of systemic IS. To this end, newborn rats were supplemented with leptin or adiponectin during the 
entirety of the suckling period. The immune status was established in plasma by the evaluation of Ig concentration 
and in the spleen by its lymphocyte phenotypical characterization and its functional ability to proliferate and to 
secrete cytokines during (day 14) and at the end of suckling period (day 21).
Results
Body and lymphoid organs’ weight. Animals supplemented with adipokines showed similar body 
weight when compared with pups receiving vehicle or Whey Protein Concentrate (WPC) (Table 1). Although 
there were no differences due to the dietary supplementation on the relative spleen weight, an increase in relative 
thymus weight was observed in the Adiponectin and WPC groups at the end of the suckling period (P < 0.05 vs. 
Reference group on day 21, Table 1).
Plasma IgA, IgM and IgG concentrations. To assess the influence of the adipokine supplementations on 
the production of antibodies in the systemic compartment, IgA, IgM, IgG and IgG isotypes (IgG1, IgG2a, IgG2b, 
IgG2c) were quantified in plasma samples during (day 14) and at the end of the suckling period (day 21) (Figs. 1 
and 2).
IgG is the most abundant Ig in plasma (Fig. 1), followed by IgM and finally IgA (Fig. 2), and with regard to IgG 
isotypes, the Th1-related IgG (IgG2b and IgG2c) were present in higher proportions than the Th2-related ones 
(IgG1 and IgG2a) (Fig. 1). Age-associated increases (between 14- and 21-d-old rats) were observed in all groups 
for IgA and IgM (P < 0.001, Fig. 2) but not for IgG (Fig. 1). However, within IgG, the 14 to 21 days age-associated 
changes were only observed in IgG2a levels in the Reference and Adiponectin groups (P < 0.01, Fig. 1C).
With reference to IgG, the three dietary supplementations did not modify their concentration in any of the 
two studied days (Fig. 1A). However, adiponectin and WPC supplementations significantly increased the pro-
portion of Th2-related Ig isotypes without affecting that of the Th1-related ones. Specifically, the pups plasma of 
Adiponectin and WPC groups had a higher percentage of IgG1 than the Reference group at day 14 (P < 0.05) 
and IgG2a at both days of the study (P < 0.01, Figs. 1B,C). Leptin supplementation was only able to increase IgG1 
abundance at day 14 (P < 0.05, Fig. 2B).
With regard to plasma IgA and IgM concentrations (Fig. 2), whereas no changes were found in IgA levels due 
to the diets, after 3 weeks of leptin or adiponectin supplementation, an increase in plasma IgM concentration was 
observed compared with the Reference group (P < 0.05 and P < 0.01, respectively). In the case of adiponectin, this 
significant increase could already be seen at day 14 (P < 0.05, Fig. 2B).
Lymphocyte composition of spleen. The percentages of B cells, T cells and their subsets TCRαβ+, 
TCRαβ+ CD4+, TCRαβ+ CD8+, TCRγδ+ and TCRγδ+ CD8+ in the lymphocyte population selected according 
to their forward-scatter characteristics (FSC) and side-scatter characteristics (SSC) from all experimental groups 
throughout the study are summarised in Figure 3.
Although there was not any significant change in B cell population between the three supplemented groups 
and the Reference group, a punctual decrease on day 14 was observed in rats supplemented with adiponectin 
compared with the Leptin group (P < 0.01, Fig. 3A). Both adipokine supplementations caused higher T-cell 
percentage than the Reference group at day 14 (P < 0.05 in the Leptin group and P < 0.01 in the Adiponectin 







Reference 37.45 ± 0.60 0.61 ± 0.02 0.38 ± 0.02
Leptin 38.04 ± 1.97 0.55 ± 0.03 0.39 ± 0.02
Adiponectin 34.32 ± 0.75 0.61 ± 0.03 0.44 ± 0.04
WPC 36.06 ± 1.69 0.65 ± 0.03 0.39 ± 0.02
Day 21
Reference 63.19 ± 1.42Ψ 0.61 ± 0.03 0.39 ± 0.02
Leptin 62.56 ± 3.02Ψ 0.62 ± 0.02Ψ 0.43 ± 0.02
Adiponectin 61.18 ± 1.75Ψ 0.62 ± 0.03 0.46 ± 0.01*
WPC 59.62 ± 1.86Ψ 0.68 ± 0.03 0.46 ± 0.02*Ψ
Table 1. Body weight, relative spleen weight and relative thymus weight from the four groups: Reference, 
Leptin, Adiponectin and Whey Protein Concentrate (WPC) over the suckling period (day 14 and 21). The 
results are expressed as a mean ± S.E.M. (n = 9−12). Statistical differences: *P < 0.05 vs. Reference group. 
ΨP < 0.05 vs. same group data at day 14.
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group, Fig. 3B). These increases in T cells induced a significant increase in the T/B cells ratio (P < 0.05, Fig. 3C). 
Conducting a deeper study into which subpopulation of T cells was responsible for this increase, on both studied 
days we found that there was a higher percentage of TCRαβ+ cells in the adipokine-supplemented animals com-
pared with that of the animals from the Reference group (P < 0.01, Fig. 3D), and more specifically an increase in 
both TCRαβ+ CD4+ and TCRαβ+ CD8+ cell percentages (P < 0.01 vs. Reference group, Figs. 3E,F). On the other 
hand, all groups showed an age-increasing proportion of T, TCRαβ+, TCRαβ+ CD4+ and TCRαβ+ CD8+ cells 
and also the T/B cells ratio (P < 0.01, Figs. 3B−F).
Despite no significant changes in TCRγδ+ and TCRγδ+ CD8+ proportions due to the supplementations, the 
Reference, Leptin and WPC groups, but not the Adiponectin group, significantly increased the proportion of 
these populations compared with percentages of these groups on day 14 (P < 0.05), because in the Adiponectin 
group similar proportion of that on day 21 had already been achieved on day 14 (Figs. 3G,H).
Moreover, Treg subset (CD4+ CD25+ Foxp3+) was also studied and neither the age nor the dietary supple-
mentations significantly modified their percentages, ranging in all cases from 0.38% to 0.73%.
Figure 1. Plasma IgG concentration after adipokine supplementation. Effect of dietary supplementation with 
adipokines on the concentration of IgG and their subclasses in plasma from the four groups − Reference, 
Leptin, Adiponectin and Whey Protein Concentrate (WPC) − over the suckling period (day 14 and 21). IgG 
(A), IgG1 (B), IgG2a (C), IgG2b (D) and IgG2c (E). The IgG subclasses were calculated as the percentage of 
each particular isotype concentration with respect to the total IgG concentration. The results are expressed as 
a mean ± S.E.M. (n = 9−12). Statistical differences: *P < 0.05 vs. Reference group. ΔP < 0.05 vs. Leptin group. 
ΨP < 0.05 vs. same group data at day 14.
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Furthermore, the study of NK, NKT cell percentage and their expression of CD8 co-receptor was also 
performed (Fig. 4). Overall, and with the only exception being the NK subset in animals supplemented with 
adiponectin, the proportion of NK and NKT cells increased with age in all groups (P < 0.05 day 21 vs. day 14, 
Figs. 4A,C). In agreement with this, the proportion of these cells co-expressing CD8, which was 65−75% for 
Figure 2. Plasma IgA and IgM concentrations after adipokine supplementation. Effect of dietary 
supplementation with adipokines on plasmatic IgA (A) and IgM (B) concentrations from the four groups − 
Reference, Leptin, Adiponectin and Whey Protein Concentrate (WPC) − over the suckling period (day 14 and 
21). The results are expressed as a mean ± S.E.M. (n = 8−12). Statistical differences: *P < 0.05 vs. Reference 
group. ΨP < 0.05 vs. same group data at day 14.
Figure 3. Main spleen cell subsets after adipokine supplementation. Effect of dietary supplementation with 
adipokines on the main splenocyte subsets from the four groups − Reference, Leptin, Adiponectin and Whey 
Protein Concentrate (WPC) − over the suckling period (day 14 and 21). B cells defined as CD45RA+ CD4− 
CD8− cells (A), T cells defined as the sum of TCRαβ+ NKR-P1A− and TCRγδ+ cells (B), ratio T/B cells (C), 
TCRαβ+ NKR-P1A− cells (D), TCRαβ+ CD4+ CD8− cells (E), TCRαβ+ CD8+ CD4− cells (F), TCRγδ+ cells 
(G) and TCRγδ+ CD8+ CD4− cells (H). The results are expressed as a mean ± S.E.M. (n = 8−12). Statistical 
differences: *P < 0.05 vs. Reference group. ΔP < 0.05 vs. Leptin group. ΨP < 0.05 vs. same group data at day 14.
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both subsets, led to an age-dependent increase, being the percentage of NK and NKT subpopulations expressing 
CD8 co-receptor higher at day 21 than at day 14 (P < 0.05), again with the exception of the Adiponectin group 
in NK cells (Figs. 4B,D). After 3 weeks of nutritional intervention, the rats supplemented with leptin showed an 
increase in the proportion of NK cell population (P < 0.05 vs. Reference and Adiponectin groups, Fig. 4A), which 
could not be significantly associated with changes in CD8 co-expression (Fig. 4B). Both adipokine supplemen-
tations were able to increase NKT percentage at day 14 (P < 0.05 and P < 0.01 vs. Reference group, respectively), 
to a proportion similar to that found in Reference animals on day 21 (>2%, Fig. 4C). At day 21, this change was 
still detected in the Leptin group with respect to the Reference and Adiponectin groups (P < 0.01 and P < 0.05, 
respectively) and, it was also significantly higher in the WPC group (P < 0.01 vs. Reference group, Fig. 4C).
Overall, spleen CD8+ lymphocytes proportion, used as an immune-maturation biomarker, increased with 
age in all groups, with the percentage at day 21 being approximately twice as high as that on day 14 (P < 0.01, 
Fig. 5A). In addition, although no effect was found at day 14, leptin and WPC supplementations induced a higher 
percentage compared with the Reference group at day 21 (P < 0.01, Fig. 5A). This pattern corresponded to the 
population of CD8+ presenting the adhesion molecule CD62L selectin in their membrane (Fig. 5B). Further anal-
ysis in CD8+ cells showed a punctual increase of 50% of CD8αβ population at day 14 in those rats supplemented 
with leptin (P < 0.05 vs. Reference group), which induced a decrease in the CD8αα/CD8αβ ratio (P < 0.05 vs. 
Reference group, Fig. 5C). Animals from the Reference group were the only ones that presented statistical differ-
ences between day 14 and day 21 in this ratio (P < 0.05) because the supplemented groups at day 14 already had 
similar levels to those of day 21 (Fig. 5C).
The proportion of cells expressing the homing αE integrin (CD103) (ranging from 0.86−1.16%), the activa-
tion marker CD25 (ranging from 1.18−1.85%) and the toll-like receptor 4 (TLR-4) (ranging from 0.21−0.81%) 
were also quantified, but there were no significant differences among the groups either at day 14 or day 21 nor was 
an age-associated pattern found.
Splenocyte proliferation and cytokine production. Splenocytes obtained from suckling rats at days 
14 and 21 were stimulated for 48 h and their ability to proliferate (Fig. 6) and secrete cytokines was determined 
(Table 2). No statistically significant differences were achieved in the lymphoproliferative response at either of 
the two studied days (Fig. 6). However, some changes were found in the cytokine production due to adipokine 
supplementation (Table 2).
There were some age-related statistical differences between days 14 and 21 in the Reference animals, such 
as for IL-2, IL-4 and IL-12, and some of these changes were also modulated by the supplementations (P < 0.05, 
Table 2). To date, differently to Reference animals, the adiponectin dietary intervention significantly lowered the 
IL-10 and IFN-γ secretion from day 21 to those present at day 14 (P < 0.05 and P < 0.01, respectively).
Figure 4. NK and NKT cell subsets after adipokine supplementation. Effect of dietary supplementation with 
adipokines on the NK defined as NKR-P1A+ TCRαβ− (A) and NKT defined as NKR-P1A+ TCRαβ+ (C) 
splenocyte subsets and their expression of CD8 co-receptor (NK CD8+ (B) and NKT CD8+ (D)) from the four 
groups − Reference, Leptin, Adiponectin and Whey Protein Concentrate (WPC) − over the suckling period 
(day 14 and 21). The results are expressed as a mean ± S.E.M. (n = 8−12). Statistical differences: *P < 0.05 vs. 
Reference group. ΔP < 0.05 vs. Leptin group. ΨP < 0.05 vs. same group data at day 14.
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Cell culture supernatants from the Leptin group showed a higher concentration of IL-4, IL-2 and IL-10 
(P < 0.05 vs. Reference group) on day 21, the first already being observed at day 14 (P < 0.05 vs. reference and 
WPC groups, Table 2). With regard to the Adiponectin group at day 14, the IL-10 secretion was increased by twice 
the amount of that produced by cells from animals in the Reference group (P < 0.05) and there was also a 4-fold 
increase in IFN-γ concentration (P < 0.01 vs. Reference group and P < 0.05 vs. WPC). At day 21, WPC supplemen-
tation showed a higher increase in IL-12p70 secretion than that observed in Reference group (P < 0.05, Table 2).
Discussion
In previous studies, we reported for the first time the impact of leptin and adiponectin supplementations on 
the intestinal immune system in suckling rats20. Nevertheless, the influence of these adipokines on the systemic 
immune compartment in early life remains unexplored. To achieve this, suckling Wistar rats were supplemented 
with leptin, adiponectin or a WPC very rich in breast milk biological factors, during the whole suckling period. 
Figure 5. Changes in CD8+ cell subsets after adipokine supplementation. Effect of dietary supplementation 
with adipokines on the CD8+ (A), CD8+ CD62L+ (B) splenocyte subsets and CD8αα/CD8αβ ratio (C) from 
the four groups − Reference, Leptin, Adiponectin and Whey Protein Concentrate (WPC) − over the suckling 
period (day 14 and 21). The results are expressed as a mean ± S.E.M. (n = 8−12). Statistical differences: 
*P < 0.05 vs. Reference group. ΨP < 0.05 vs. same group data at day 14.
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The current study demonstrates that adipokine supplementation during the suckling period is able to stimulate 
the systemic IS in early life. This effect is associated with an increase in the plasma Ig concentrations and changes 
in spleen lymphocyte composition and the pattern of cytokine secretion. However, a current limitation of this 
experimental design is the fact that plasmatic leptin and adiponectin levels in pups were not evaluated after sup-
plementation. Nevertheless, previous studies described the presence of leptin in serum of supplemented-rats21 
and adiponectin in mice22 confirming the absorption of both adipokines. In addition, although the most abun-
dant form of adiponectin in human milk is the high molecular weight multimer23 we have supplemented the rats 
with the monomeric form.
Even though the supplementations were administered daily to Wistar rats from the day of birth and through-
out the suckling period, they did not affect either their body weight growth. These results are in line with some 
previous studies where the supplementation with these adipokines did not modify body weight20,24. Moreover, 
taking into account the long-term effect of such adipokines, it has been described that leptin and adiponectin 
levels in breast milk during the perinatal period might be associated with a higher risk of body weight gain and 
overweight in the corresponding infants in later life13,25. This fact reinforces the important role they have in the 
regulation of metabolism26 and metabolic diseases such as obesity or diabetes16,27.
Although there is a study carried out by Hick et al.28 in which the mice received leptin injections for 10 days 
showing a decrease in thymus weight, we have not seen these effects due to the leptin supplementation during 
the suckling period. However, supplementations with adiponectin and WPC for 3 weeks increased the relative 
thymus weight. This is the first time that such an effect on the thymus by these compounds has been reported, 
although it has been previously described that the thymus of exclusively breastfed babies is double that of chil-
dren who are fed with formula29. So, adiponectin, present in breast milk, might be one of the active components 
that increases the weight of the thymus and therefore to have a role in immunodevelopment at such level. In 
this regard, the similar effect induced by either adiponectin or WPC, which has high concentration of bioactive 
Figure 6. Splenocyte proliferation after adipokine supplementation. Effect of dietary supplementation with 
adipokines on proliferation rate in mitogen-stimulated splenocytes from the four groups − Reference, Leptin, 
Adiponectin and Whey Protein Concentrate (WPC) − over the suckling period (day 14 and 21). The results are 




Reference Leptin Adiponectin WPC
IL-2 348.92 ± 63.45 352.52 ± 104.37 600.95 ± 183.86 343.96 ± 42.48
IL-4 69.90 ± 9.64 202.85 ± 61.59* 91.82 ± 14.21 71.60 ± 13.36Δ
IL-10 148.92 ± 10.67 196.88 ± 53.91 364.38 ± 91.44* 222.87 ± 46.17
IL-12p70 179.15 ± 48.41 110.42 ± 39.27 216.42 ± 28.44 335.67 ± 123.88
IFN-γ 381.65 ± 92.64 1379.88 ± 679.35 1834.42 ± 338.28* 400.22 ± 31.33Φ
TNF-α 15.81 ± 3.93 43.46 ± 19.28 29.26 ± 6.87 20.52 ± 1.64
Day 21
IL-2 185.90 ± 41.54Ψ 286.66 ± 16.59* 139.84 ± 43.46ΔΨ 222.43 ± 53.99
IL-4 35.09 ± 7.78Ψ 71.59 ± 9.95*Ψ 35.54 ± 10.24Ψ 52.27 ± 12.70
IL-10 188.52 ± 12.75 239.88 ± 10.69* 185.99 ± 18.31Ψ 204.16 ± 9.91Δ
IL-12p70 283.64 ± 13.04Ψ 317.26 ± 25.59Ψ 296.60 ± 37.97 353.58 ± 24.76*
IFN-γ 802.84 ± 172.31 1360.82 ± 267.48 801.19 ± 170.70Ψ 1117.86 ± 220.70
TNF-α 30.54 ± 6.26 48.52 ± 5.08 28.62 ± 8.58 38.21 ± 8.79
Table 2. Cytokine pattern secreted by splenocytes from the four groups: Reference, Leptin, Adiponectin 
and Whey Protein Concentrate (WPC) over the suckling period (day 14 and 21). The results are expressed 
as a mean ± S.E.M. (n = 9–12). The quantitative determinations were performed with the following limits of 
detection: 2.10 pg/mL for IL-2; 0.85 pg/mL for IL-4; 14 pg/mL for IL-10; 4.93 pg/mL for IL-12p70; 4.35 pg/mL 
for IFN-γ; and 3.08 pg/mL for TNF-α. Statistical differences: *P < 0.05 vs. Reference group. ΔP < 0.05 vs. Leptin 
group. ΦP < 0.05 vs. Adiponectin group. ΨP < 0.05 vs. same group data at day 14.
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factors on the thymus, reinforces the effect of the first on this lymphoid organ. However, further studies of the 
possible cellular and histological changes induced in the thymus by both supplementations should be addressed.
The current plasma concentrations of inmunoglobulins in the Reference group presented in this study 
showed similar levels of IgG, IgA and IgM to those described previously in age-matched Lewis rats30. Regarding 
plasma IgG concentrations, neither of the three supplementations produced any effect on them. Furthermore, 
the four plasma rat IgG isotypes were also quantified: IgG1 and IgG2a, which have been associated with a type 
Th2 immune response, and IgG2b and IgG2c, related to Th131,32. Suckling rats fed with leptin showed a punctual 
increase of IgG1 at day 14, a result that did not match with the suggested leptin effect on the switch from IgG1 to 
IgG2a isotype33–35. Moreover, animals fed with adiponectin increased IgG1 and IgG2a in the same way as WPC 
supplementation, suggesting an early maturation similar to that found for this positive control product with 
immunomaturative properties36. Although no one has described before the effects of adiponectin on plasma IgG 
isotypes, these results on adipokine increased Th2-related Ig are in line with the anti-inflammatory effects that 
are attributed to adiponectin12,26,37. In addition, it is well known that, even though there are relatively high levels 
of B cells at birth, the production of Ig during the postnatal period is far from that produced in adults38. So, the 
increase of IgM due to the adiponectin supplementation at both studied days and leptin at day 21 could also sug-
gest a role of these adipokines in the early maturation of their adaptive immunity.
In the present study, we describe for the first time, to the best of our knowledge, the effect of the adipokines 
on the lymphocyte composition in the spleen, which is a relevant lymphoid tissue in the systemic compartment. 
Moreover, in all of the main spleen lymphocyte subsets in the Reference group, with the exception of B cells, there 
was an age-related increase in accordance with previous studies describing the development of the IS during the 
postnatal period30,38,39. In this study, none of the three supplementations altered the splenocytes’ percentage of B, 
Treg and TCRγδ+ cells. However, rats fed with leptin were able to increase the T cell proportion by increasing the 
T/B cells ratio at both day 14 and 21. This adipokine was also able to enhance TCRαβ+ and TCRαβ+ CD8+ cell 
proportion at both studied days. This effect strengthens the ability of this adipokine to increase these populations 
previously described in the intestinal compartment20. Moreover, the Adiponectin group increased these popu-
lations proportions at day 14. Controversially, Wilk et al.40 showed that adiponectin could negatively regulate 
human CD8+ T cells. We also found here that both adipokine supplementations increased the percentage of Th 
cells (TCRαβ+ CD4+) leptin at both days, and adiponectin only at day 14. This last result was in concordance with 
other studies that evidenced that leptin induces the proliferation of CD4+ T cells41,42.
With regard to NK and NKT cells, it has been previously described that leptin is able to increase the develop-
ment and activation of NK cells both in vitro and in vivo18,43–45, in a similar way to what was observed in this study 
on rats supplemented with leptin. Although no differences were observed in the NKT population in the intestinal 
compartment20, the three supplementations increased NKT and NKT CD8+ cell percentages in the spleen. To bet-
ter understand neonatal systemic immunity, the total proportion of cells bearing CD8+ was studied. Rats fed with 
leptin or WPC showed a remarkable increase of CD8+ cells proportion at the end of the suckling period. The role 
of leptin in enhancing CD8+ splenocytes was also described in mice46 and in the intestinal compartment of rats20. 
Moreover, human studies also demonstrate this effect in vitro17,19. In the current study, this enhancement could be 
attributed to the higher CD8+ CD62L+ cell percentage. The CD62L molecule is involved in lymphocyte homing47. 
The increase in the proportion of this specific population could mean that the leptin and WPC supplementations 
increased the arrival of lymphocytes to the spleen and, consequently, their activation. Alternatively, it could also 
indicate an induction of adhesion molecules in the early phase of homing to other tissues.
Another aspect studied in the spleen was the lymphocyte proliferation after in vitro stimulation. Although 
none of the splenocytes from any of the studied groups presented any change after 48 h with anti-CD3/anti-CD28 
stimulation, cells from the intestinal compartment of rats supplemented with adiponectin showed an increase in 
lymphoproliferative capacity20. However, some differences were found in the cytokine secretion pattern. Overall, 
leptin supplementation was able to increase IL-4 at both studied days, and IL-2 and IL-10 at the end of the suck-
ling period. Thus, the rise in IL-4 due to leptin at both ages may be linked to the enhancement in the IgG1 (Th2 
isotype) rise at day 14 described before. Moreover, the IL-2 increase can be justified on the basis that there are 
some studies showing that leptin can enhance T CD4+ lymphocyte activation by stimulating the synthesis of 
IL-217,48. Additionally, these results are in line with our previous results, which showed that the supplementation 
with these adipokines produced an increase of IL-2 and IL-4 by lymphocytes from mesenteric lymph nodes20. 
With regard to the IL-10 increase, leptin showed a role in the activation of B lymphocytes, inducing secretion of 
the anti-inflammatory and immunoregulatory cytokine IL-10 via JAK–STAT and p38MAPK–ERK1/2 signal-
ling49, so the increase of the secretion of this cytokine could be due to the activation of this pathway.
Moreover, we found an increase of IL-10 and IFN-γ in those rats supplemented with adiponectin at day 14. 
Some human and in vitro studies also show the anti-inflammatory role of adiponectin, by decreasing TNF-α or 
enhancing IL-10 levels15,50,51. On the other hand, our result regarding IFN-γ did not match with those reported 
previously, where a decrease of this cytokine was found by adiponectin50,52. But it has to be mentioned that both 
studies were performed with other types of cells and they were conducted in human and mice.
Furthermore, an association between these adipokines and the IS has also been reported in autoimmune 
diseases, such as systemic lupus erythematosus or rheumatoid arthritis34,52. In line with this, high concentration 
of leptin and adiponectin has been detected in serum of patients with these diseases16,37. Unfortunately, the effect 
of these adipokines on children’s immunity or in later life remains still un-explored. In our study we showed the 
early maturation of the systemic IS during the suckling period due to the supplementation of leptin or adiponec-
tin but, further studies should be addressed to elucidate whether these adipokines could have a programming 
effect and therefore modulate immune responses later in life.
In conclusion, supplementations with adipokines, leptin or adiponectin, during the whole suckling period 
involve immunomodulatory effects in the systemic immune response in rats at early life. With regard to the 
developing humoral response, both adipokines modulated IgG isotype proportions and also increased IgM levels, 
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suggesting an early maturation of B cells secreting high levels of Ig, which is deficient in newborns. This study 
also demonstrates the impact of these adipokine supplementations on the lymphocyte composition, showing a 
remarkable induction of maturation of acquired immunity, particularly on T cells, by increasing the proportion 
of TCRαβ+ CD4+ and TCRαβ+ CD8+ subpopulations. In addition, NKT cell subset development was also pro-
moted by both adipokines. Furthermore, supplementation of both adipokines modulated the cytokine pattern 
secreted by splenocytes. In summary, these changes might contribute to enhancing the immature immune system 
of the newborn, thereby underlining the maturative role of leptin and adiponectin in this period for enhancing 
early IS development.
Materials and Methods
Animals. Sixteen G15 pregnant Wistar rats (RjHan:WI strain) from Janvier Labs (Le Genest-Saint-Isle, 
France) were individually housed in cages and monitored daily. The animals were housed under controlled tem-
perature and humidity conditions, in a 12:12 h light:dark cycle in the Faculty of Pharmacy and Food Science 
animal facilities in non-specific pathogen free conditions. With regard to sample size estimation, four litters were 
required for each group as previous studies have demonstrated a notable role of variability among litters53. This 
calculation was made by the Appraising Project Office’s programme from the Universidad Miguel Hernández 
de Elche (Alicante), used to provide statistically significant differences among groups, assuming that there is no 
dropout rate and a type I error of 0.05 (two-sided). All the experimental procedures were performed in accord-
ance with the Guide for the Care and Use of Laboratory Animals. The study was reviewed and approved by the 
Ethical Committee for Animal Experimentation of the University of Barcelona (CEEA/UB ref. 220/15).
Dams were fed with commercial diet corresponding to the American Institute of Nutrition 93 M formulation 
(Harlan Teklad, Madison, Wisconsin, USA) and water ad libitum. Pregnant rats were allowed to deliver at term. 
The day after birth was registered as day 1 of life. Litters were assigned to the experimental groups and culled to 9 
pups per lactating dam. Pups had free access to the nipples and the rat diet and they were individually identified 
and weighed daily. Handling was done in the same time range to avoid the influence of biological rhythms.
Dietary supplementation. According to the oral supplementation given, suckling rats were randomly dis-
tributed into four groups (n = 4 dams with 9 pups each/group; n = 36 pups/group): the Reference, the Leptin, the 
Adiponectin and the Whey Protein Concentrate (WPC) groups. As WPC is rich in bioactive and immune factors 
it was used as a product expected to have immunomodulatory impact on neonatal rats, as suggested in previous 
studies36,54. The first 21 days of a rat’s life correspond to the lactating period of humans, thus the supplementa-
tion during the first 21 days fits the entire suckling period. Daily, pups received the supplements by oral gavage 
using low-capacity syringes (Hamilton Bonaduz, Bonaduz, Switzerland) adapted to oral 25- or 23-gauge gavage 
tubes (ASICO, Westmont, IL, USA), as previously described36. Litters were separated from dams half an hour 
before oral supplementation to allow gastric emptying. The Leptin group was supplemented with 0.7 μg/kg/day 
of recombinant rat leptin (PeproTech®, Rocky Hill, NJ, USA) in water; the Adiponectin group was administered 
with recombinant murine adiponectin (PeproTech®) solution at a dose of 35 μg/kg/day in water; the WPC group 
received Lacprodan® MFGM-10 (Arla Foods Ingredients Group, Diby, Denmark) at a dose of 0.3 g/kg/day in 
water. Administered doses of all supplementations were selected in basis of other similar studies55–58 and as per-
formed in a previous approach20. The Reference group was administered with the same volume of water (vehicle) 
as the supplemented groups (10 mL/kg/day).
Sample collection and processing. During (day 14) and at the end of the suckling period (day 21), 3 pups 
of each mother (12 rats/group/day) were weighed and intramuscularly anaesthetised with ketamine (9 mg/kg) 
(Merial Laboratories S.A., Barcelona, Spain) and xylazine (10 mg/kg) (Bayer A.G., Leverkusen, Germany). Apart 
from blood samples, spleen and thymus were collected and weighed under sterile conditions. Blood samples were 
centrifuged and plasma was kept at −20 °C for Ig determination.
Ig quantification. Plasma IgA, IgM, IgG1, IgG2a, IgG2b and IgG2c concentrations were quantified by 
ProcartaPlex Rat Antibody Isotyping Panel (eBioscience, Frankfurt, Germany), following the manufacturer’s 
instructions. Each Ig isotype concentration was quantified according to the different detection antibodies con-
jugated to phycoerythrin and analysed by the Luminex MAGPIX analyser (Luminex®, Austin, TX, USA) at the 
Scientific and Technological Centres of the University of Barcelona (CCiT-UB). Assay sensitivity was as follows: 
0.48 pg/mL for IgA; 0.02 ng/mL for IgM; 0.78 ng/mL for IgG1; 0.02 ng/mL for IgG2a; 0.11 ng/mL for IgG2b and 
0.19 pg/mL for IgG2c.
Spleen lymphocytes isolation. Splenocytes were isolated, as previously described59, by passing the tissue 
individually through a sterile 40 µm mesh cell strainer (Thermo Fisher Scientific, Barcelona, Spain). The resultant 
cell suspensions were submitted to the osmotic lyses of erythrocytes. Cell counting and viability were assessed 
by CountessTM Automated Cell Counter (InvitrogenTM, Thermo Fisher Scientific). Splenocytes were then used 
to study their phenotype, and their proliferation capacity and cytokine production, after mitogenic stimulation.
Immunofluorescence staining and flow cytometry analysis. For flow cytometric analysis, sple-
nocytes (2 × 105) were labelled with mouse anti-rat monoclonal antibodies (mAb) conjugated to fluorescein 
isothiocyanate (FITC), phycoerythrin (PE), peridininchlorophylla protein (PercP), allophycocyanin (APC) 
or APC-Cyanine (Cy)7, as in previous studies60. In this case, the antibodies used were anti-CD4, anti-CD8α, 
anti-CD8β, anti-TCRαβ, anti-TCRγδ, anti-NKR-P1A, anti-CD25, anti-CD45RA (BD Biosciences, San Diego, 
USA), anti-CD62L, anti-CD103 (Biolegend, San Diego, CA, USA), anti-TLR-4 (Novus Biologicals, Littlon, CO, 
USA) and anti-Foxp3 (eBioscience). After staining with standard procedures20, analyses were performed using a 
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GalliosTM Cytometer (Beckman Coulter Inc., Miami, FL, USA) at the CCiT-UB. All results were assessed by the 
Flowjo v.10 software (TreeStar, Inc., Ashland, OR, USA).
Proliferation assay and cytokine production in stimulated splenocytes. At day 14 and 21, sple-
nocytes (105 cells/200 µL) were incubated in quadruplicate with the anti-CD3 mAb (10 µg/mL, BD Biosciences) 
and anti-CD28 mAb (20 µg/mL, BD Biosciences) or without stimulus in 96-well plates (TPP, Trasadingen, 
Switzerland). Stimulated cells (SC) and non-stimulated cells (NSC) were incubated in sterile conditions for 48 h 
at 37 °C and 5% CO2 atmosphere in a humidified chamber. At 46 h, 5-bromo- 2′-deoxyuridine was added and 2 h 
later plates were then centrifuged (210 g, 5 min) and proliferation was quantified by means of the Cell Proliferation 
Assay Kit (Merck Millipore, Darmstadt, Germany), following the manufacturer’s instructions. Absorbance (Abs), 
was measured at 450 nm on a microplate photometer (Labsystems Multiskan, Helsinki, Finland). The prolifera-
tion rate was expressed as A/B, where, A = [(Abs-SC – Abs-NSC) / Abs-NSC] for the supplemented group and the 
mean value of B = [(Abs-SC – Abs-NSC)/Abs-NSC] for the Reference group.
To assess cytokine production, IL-2, IL-4, IL-10, IL-12p70, IFN-γ, and TNF-α were quantified from super-
natants after the above-described stimulation, also using a ProcartaPlex® multiplex immunoassay (eBioscience), 
according to the manufacturer’s protocol and previous studies20. Results were analysed by the Luminex MAGPIX 
analyser (Luminex®) at the CCiT-UB.
Statistical analysis. Statistics were performed by the software IBM Statistical Package for the Social 
Sciences (SPSS, version 22.0, Chicago, IL, USA). The Levene’s test was carried out to assess the homogeneity of 
variance and the Shapiro−Wilk test to evaluate the distribution of the results. Conventional one-way ANOVA 
test followed by the Bonferroni post hoc test was performed when there was a normal distribution and equality of 
variance existed. On the other hand, the results having different variance and/or different distribution were eval-
uated by the non-parametric Kruskal−Wallis test followed by the Mann−Whitney U post hoc test. Significant 
differences were established at P < 0.05.
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